Longevity Vision Fund
Longevity Vision Fund is a New York–based venture capital firm founded in 2019 that manages a $100 million fund dedicated to longevity. It backs companies developing technologies and services that extend healthy lifespans and address aging-associated health challenges, with seed to Series C investments. The firm prioritizes preventive medicine, early detection, medical technologies and devices, artificial intelligence in healthcare, longevity therapies, regenerative medicine, and healthcare infrastructure, aiming to make affordable longevity accessible to all. As a registered investment adviser, Longevity Vision Fund aligns capital with milestones that validate market potential and drive value for portfolio companies.
Top Stages
Past deals in British Virgin Islands
Juvenescence
Series B in 2019
Juvenescence is a British Virgin Islands-based company focused on investing in human aging and longevity. It aims to extend both lifespan and healthspan by developing therapeutics that slow aging and treat age-related diseases. The company creates and partners with new ventures, in-licenses compounds, or forms joint ventures to build an ecosystem of assets targeting aging, regeneration, and related diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.